Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO) : a phase 3 randomised double-blind active-controlled trial in Lancet (The), Vol. 378, n° 9787 (16 juillet 2011) 
 | ||||||||||||||||||||||||||||
|
[article]
|
